Takeda Puts Up $247M For Brazilian Drugmaker Multilab
The Osaka-based drug manufacturer said it planned to complete the Multilab acquisition later this year. The deal includes a $246.7 million upfront cash payment by Takeda and future milestone payments to Multilab senior management of up to $19.7 million, the buyer said.
Additional financial details of the acquisition were not disclosed. Spokespeople for Takeda and...
To view the full article, register now.